Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis

Molecular Carcinogenesis

Volumn 31, Issue 2, 2001, Pages 74-82

  Devereux, Theodora R ^a   Stern, Mariana C ^a   Flake, Gordon P ^a   Yu, Mimi C ^b   Zhang, Zhen Quan ^c   London, Stephanie J ^a   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Guangxi Cancer Institute   (China)

Author keywords

Collagenase type IV; Epidermis; Tissue inhibitor of metalloproteinase 2; Tumorigenicity

Indexed keywords

GELATINASE A; GELATINASE B; MUTAGENIC AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; DNA TRANSCRIPTION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; GENE ACTIVATION; KERATINOCYTE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CELL; SPINDLE CELL CARCINOMA;

ANIMALS; BINDING SITES; BLOTTING, WESTERN; CARCINOMA; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; KERATINOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SKIN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034964102     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.1042     Document Type: Article

References (37)

1. Matrix metalloproteinases
2. The structure of the human skin fibroblast collagenase gene
3. Stromelysin, a connective tissue - Degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase: Biosynthesis, isolation, characterization and substrates
4. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: Purification and characterization
5. Characterization of gelatinase from pig polymorphonuclear leucocytes: A metalloproteinase resembling tumor type IV collagenase
6. Matrix metalloproteinases: Multifunctional contributors to tumor progression
7. Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes
8. Induction of collagenase secretion in human fibroblast cultures by growth promoting factors
9. 2 production by human synovial cells and dermal fibroblasts
10. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1
11. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
12. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells
13. Independent regulation of collagenase, 72-kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor beta
14. Positive and negative transcriptional elements of the human type IV collagenase gene
15. Tissue inhibitors of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions
16. Oncogene activation in chemical carcinogenesis
17. Pathology of human and experimental skin tumors
18. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice
19. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo
20. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding
21. Binding of wild type and mutant forms of p53 protein from human tumors to a specific DNA sequence of the first intron of the H-ras oncogene
22. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
23. High levels of phosphorylated c-Jun, Fra-1 and ATF-2 proteins correlate with malignant phenotypes in multistage mouse skin carcinogenesis model
24. Constitutive production of procollagenase and tissue inhibitor of metalloproteinases by human ceratinocytes in culture
25. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
26. Altered epidermal growth factor signal transduction in activated Ha-ras transformed human keratinocytes
27. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression
28. Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes
29. Signal transduction through MAP kinase cascades
30. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes
31. The AP-1 sequence is necessary, but not sufficient for phorbol induction of collagenase in fibroblasts
32. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras
33. Oncogenic and transcriptional cooperation with Ha-ras requires phosphorylation of c-jun on serines 63 and 73
34. Regulation of 92kDa type IV collagenase expression by the jun amino-terminal kinase and the extracellular signal-regulated kinase-dependent signaling cascades
35. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin
36. Preclinical and clinical studies of MMP inhibitors in cancer